These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 38935965)

  • 1. Mutational Patterns Observed in SARS-CoV-2 Genomes Sampled From Successive Epochs Delimited by Major Public Health Events in Ontario, Canada: Genomic Surveillance Study.
    Chen D; Randhawa GS; Soltysiak MP; de Souza CP; Kari L; Singh SM; Hill KA
    JMIR Bioinform Biotechnol; 2022 Dec; 3(1):e42243. PubMed ID: 38935965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of 3.5 million SARS-CoV-2 sequences reveals unique mutational trends with consistent nucleotide and codon frequencies.
    Fumagalli SE; Padhiar NH; Meyer D; Katneni U; Bar H; DiCuccio M; Komar AA; Kimchi-Sarfaty C
    Virol J; 2023 Feb; 20(1):31. PubMed ID: 36812119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline Sequencing Surveillance of Public Clinical Testing, Hospitals, and Community Wastewater Reveals Rapid Emergence of SARS-CoV-2 Omicron Variant of Concern in Arizona, USA.
    Smith MF; Holland SC; Lee MB; Hu JC; Pham NC; Sullins RA; Holland LA; Mu T; Thomas AW; Fitch R; Driver EM; Halden RU; Villegas-Gold M; Sanders S; Krauss JL; Nordstrom L; Mulrow M; White M; Murugan V; Lim ES
    mBio; 2023 Feb; 14(1):e0310122. PubMed ID: 36622143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Surveillance of SARS-CoV-2 M
    Lee JT; Yang Q; Gribenko A; Perrin BS; Zhu Y; Cardin R; Liberator PA; Anderson AS; Hao L
    mBio; 2022 Aug; 13(4):e0086922. PubMed ID: 35862764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrasting Epidemiology and Population Genetics of COVID-19 Infections Defined by Multilocus Genotypes in SARS-CoV-2 Genomes Sampled Globally.
    Chan FHM; Ataide R; Richards JS; Narh CA
    Viruses; 2022 Jun; 14(7):. PubMed ID: 35891414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational signature dynamics indicate SARS-CoV-2's evolutionary capacity is driven by host antiviral molecules.
    Lamb KD; Luka MM; Saathoff M; Orton RJ; Phan MVT; Cotten M; Yuan K; Robertson DL
    PLoS Comput Biol; 2024 Jan; 20(1):e1011795. PubMed ID: 38271457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Omicron Variant Genomic Sequences and Their Epidemiological Correlates Regarding the End of the Pandemic: In Silico Analysis.
    Kumar A; Asghar A; Singh HN; Faiq MA; Kumar S; Narayan RK; Kumar G; Dwivedi P; Sahni C; Jha RK; Kulandhasamy M; Prasoon P; Sesham K; Kant K; Pandey SN
    JMIR Bioinform Biotechnol; 2023; 4():e42700. PubMed ID: 36688013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Canadian VirusSeq Data Portal and Duotang: open resources for SARS-CoV-2 viral sequences and genomic epidemiology.
    Gill EE; Jia B; Murall CL; Poujol R; Anwar MZ; John NS; Richardsson J; Hobb A; Olabode AS; Lepsa A; Duggan AT; Tyler AD; N'Guessan A; Kachru A; Chan B; Yoshida C; Yung CK; Bujold D; Andric D; Su E; Griffiths EJ; Van Domselaar G; Jolly GW; Ward HKE; Feher H; Baker J; Simpson JT; Uddin J; Ragoussis J; Eubank J; Fritz JH; Gálvez JH; Fang K; Cullion K; Rivera L; Xiang L; Croxen MA; Shiell M; Prystajecky N; Quirion PO; Bajari R; Rich S; Mubareka S; Moreira S; Cain S; Sutcliffe SG; Kraemer SA; Alturmessov Y; Joly Y; Cphln Consortium ; CanCOGeN Consortium ; VirusSeq Data Portal Academic And Health Network ; Fiume M; Snutch TP; Bell C; Lopez-Correa C; Hussin JG; Joy JB; Colijn C; Gordon PMK; Hsiao WWL; Poon AFY; Knox NC; Courtot M; Stein L; Otto SP; Bourque G; Shapiro BJ; Brinkman FSL
    Microb Genom; 2024 Oct; 10(10):. PubMed ID: 39401061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The status and analysis of common mutations found in the SARS-CoV-2 whole genome sequences from Bangladesh.
    Rahman S; Shishir MA; Hosen MI; Khan MJ; Arefin A; Khandaker AM
    Gene Rep; 2022 Jun; 27():101608. PubMed ID: 35399222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variant-specific deleterious mutations in the SARS-CoV-2 genome reveal immune responses and potentials for prophylactic vaccine development.
    Islam MA; Shahi S; Marzan AA; Amin MR; Hasan MN; Hoque MN; Ghosh A; Barua A; Khan A; Dhama K; Chakraborty C; Bhattacharya P; Wei DQ
    Front Pharmacol; 2023; 14():1090717. PubMed ID: 36825152
    [No Abstract]   [Full Text] [Related]  

  • 11. Mutations of SARS-CoV-2 Structural Proteins in the Alpha, Beta, Gamma, and Delta Variants: Bioinformatics Analysis.
    Khetran SR; Mustafa R
    JMIR Bioinform Biotechnol; 2023; 4():e43906. PubMed ID: 37485046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 genome surveillance: A geographical landscape and mutational mapping of SARS-CoV-2 variants in central India over two years.
    Khairnar K; Tomar SS
    Virus Res; 2024 Jun; 344():199365. PubMed ID: 38527669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal Dynamics and Evolution of SARS-CoV-2 Demonstrate the Necessity of Ongoing Viral Genome Sequencing in Ontario, Canada.
    Sjaarda CP; Guthrie JL; Mubareka S; Simpson JT; Hamelin B; Wong H; Mortimer L; Slinger R; McArthur AG; Desjardins M; McGeer A; Mazzulli T; Douchant K; Brabant-Kirwan D; Fattouh R; Campigotto A; Patel SN; Fittipaldi N; Colautti RI; Sheth PM
    mSphere; 2021 May; 6(3):. PubMed ID: 33952657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of SARS-CoV-2 genome evolutionary patterns.
    Gupta S; Gupta D; Bhatnagar S
    Microbiol Spectr; 2024 Feb; 12(2):e0265423. PubMed ID: 38197644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large scale analysis of the SARS-CoV-2 main protease reveals marginal presence of nirmatrelvir-resistant SARS-CoV-2 Omicron mutants in Ontario, Canada, December 2021-September 2023.
    Duvvuri V; Shire F; Isabel S; Braukmann T; Clark S; Marchand-Austin A; Eshaghi A; Bandukwala H; Varghese N; Li Y; Sivaraman K; Hussain H; Cronin K; Sullivan A; Li A; Zygmunt A; Ramotar K; Kus J; Hasso M; Corbeil A; Gubbay J; Patel S
    Can Commun Dis Rep; 2024 Oct; 50(10):365-374. PubMed ID: 39386278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of the effects of the top 10 synonymous mutations from 26645 SARS-CoV-2 genomes of early pandemic phase.
    Boon WX; Sia BZ; Ng CH
    F1000Res; 2021; 10():1053. PubMed ID: 39268187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Canadian VirusSeq Data Portal & Duotang: open resources for SARS-CoV-2 viral sequences and genomic epidemiology.
    Gill EE; Jia B; Murall CL; Poujol R; Anwar MZ; John NS; Richardsson J; Hobb A; Olabode AS; Lepsa A; Duggan AT; Tyler AD; N'Guessan A; Kachru A; Chan B; Yoshida C; Yung CK; Bujold D; Andric D; Su E; Griffiths EJ; Van Domselaar G; Jolly GW; Ward HKE; Feher H; Baker J; Simpson JT; Uddin J; Ragoussis J; Eubank J; Fritz JH; Gálvez JH; Fang K; Cullion K; Rivera L; Xiang L; Croxen MA; Shiell M; Prystajecky N; Quirion PO; Bajari R; Rich S; Mubareka S; Moreira S; Cain S; Sutcliffe SG; Kraemer SA; Joly Y; Alturmessov Y; Consortium C; Consortium C; ; Fiume M; Snutch TP; Bell C; Lopez-Correa C; Hussin JG; Joy JB; Colijn C; Gordon PMK; Hsiao WWL; Poon AFY; Knox NC; Courtot M; Stein L; Otto SP; Bourque G; Shapiro BJ; Brinkman FSL
    ArXiv; 2024 May; ():. PubMed ID: 38764594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Rate of Mutational Events in SARS-CoV-2 Genomes across Brazilian Geographical Regions, February 2020 to June 2021.
    de Souza UJB; Dos Santos RN; Campos FS; Lourenço KL; da Fonseca FG; Spilki FR; Corona-Ômica Br/McTi Network
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive profile of SARS-CoV-2 variants spreading during the COVID-19 pandemic: a genomic characterization study from Chhattisgarh State, India.
    Negi SS; Sharma K; Bhargava A; Singh P
    Arch Microbiol; 2024 Jan; 206(2):68. PubMed ID: 38238530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Genomics Reveals Early Emergence and Biased Spatiotemporal Distribution of SARS-CoV-2.
    Chiara M; Horner DS; Gissi C; Pesole G
    Mol Biol Evol; 2021 May; 38(6):2547-2565. PubMed ID: 33605421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.